Establishing a mouse model of disease to test combined antisense oligonucleotides and AAV systemic gene therapy as new treatment for Oculopharyngeal muscular dystrophy

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/21 → 31/08/22

Funding

  • AFM Telethon: £40,323.00